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 abstract 
 medical implications 
 introduction 
 results 
 research goals 
1. Perform various gold nanoparticle syntheses and analyze the varying size, 
surface chemistry, and hydrophilicity the nanoparticles to determine their 
effects on drug delivery. 
2. Measure the leakage rate of fluorescent dye from lipid-nanoparticle vesicles to 
simulate stimuli responsive drug delivery.  
3. Tailor nanoparticle surface chemistry to increase stability and bioavailability, 
decrease macrophage uptake, and enable site-specific targeting. 
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Hydrophilic GNPs: 
• Citrate(-) 
• Carboxymethyl cellulose, CMC(-) 
• Polyethylene imine, PEI(+) 
• Polyethylene glycol, PEG(0) 
• Dipalmitoylphosphatidylcholine, DPPC 
(+/-). 
oDetermine hydrophilic GNP effect on leakage 
when exteriorly bound to phospholipid 
vesicles 
 
Hypothesis:   
• Size and hydrophilicity will increase rate of fluorescent dye 
release.   
• GNPs will cause enhancement of fluorescent dye 
 
Future Goals: 
a. 
In the near future, new pharmaceutical therapeutics will evolve to contain complicated protein 
molecules, gene therapies, etc., which must be transported in extremely specific environments 
such as a specific pH level or sodium concentration.  The problem is that throughout the body 
there are many different environments that a drug could pass through.  For example, gastric 
acid can have pH levels as low as 1 where blood is around 7.4.  This is a problem because as 
the drugs pass through these harsh environments they may become rendered useless.  
Furthermore, these new therapeutics are not compatible with conventional drug delivery 
mechanisms and new strategies for drug delivery are required.  To solve these problem 
phospholipid vesicles are being used with gold nanoparticles to transport these drugs.  The 
vesicles encapsulate the drug of choice and protect it from the harsh environments of the body.  
The gold nanoparticles can be designed to either embedded in the lipid bilayer of the vesicles 
or decorate the vesicle exterior.  When radiation is applied, the nanoparticles are excited and 
cause a disruption in the vesicle structure, leading to the release of the drug into the body.  Our 
research is centered around how the stability of the lipid vesicles changes based on the size, 
surface chemistry, and distribution of the nanoparticles.   
Nanoparticle Characterization: 
• Hydrodynamic diameter accounts for the gold 
core, the ligand length, and the hydrodynamic 
barrier surrounding the NP 
• Poly-dispersity index (PDI) shows that our 
solutions contain a range of sizes, or 
conglomerates 
• Zeta results need to be near +/- 30 
• UV – VIS shows that colloidal gold exists in 
solution 
Importance of Characterization: 
• Alterations in the nanoparticle surface chemistry 
and ligand types can engender different effects on 
the leakage rates and stability. 
• Understanding the variances between the surface 
chemistries of the nanoparticles provides an 
accurate evaluation and analysis of these effects. 
 
    Hydrophobic GNPs: 
• DDT is used as capping agent
• Size range is 2-6 nm for averages 
• Drugs are encapsulated in vesicle 
• Particles embedded in bilayer 
• GNPs are used to disrupt the vesicle 
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The vesicles will help the medicine inside travel through 
the harsh conditions that they will have to endure while 
inside the body. The vesicles can be tracked in the blood 
stream and then leaked into the body when thermal 
radiation is applied. The vesicles must be stable enough to 
endure the temperature of the body without rupturing, but 
must also break under temperatures that the human body 
can easily tolerate. If this can be achieved, then the patient 
will be put under the least amount of stress and the 
medicine will be delivered most efficiently. 
Mean 4.608 
Standard 
Deviation 
3.84 
Range 60.62 
Mean 3.22 
Standard 
Deviation 
.9968 
Range 10.52 
Mean 2.95 
Standard 
Deviation 
.6636 
Range 5.48 
    Experiments with GNPs: 
• Determine how to control the size and distribution of size 
• Conduct experiments varying size of nanoparticles in 
vesicles 
• Conduct experiments to determine temperature of release  
 
Results 
As the data shows the fractionation 
does a very good job of creating 
different size dispersions.  The range 
and the number average (mean) show 
exactly how well the fractionation 
process works.  Also, the standard 
deviation continues to lower as the 
percent of methanol is raised.  This is 
desired for the present because the 
lowest size is the most important, but 
more monodispersed distributions for 
higher averages will be required as 
research continues.  Procedures will be 
developed to lower the standard 
deviation of the lower percent methanol 
fractionations.  
Nanoparticles and Liposomes: 
• In order to create the vesicle-nanoparticle 
assembly, nanoparticles can be synthesized and 
then exteriorly associated with vesicles through 
electrostatic adsorption. 
Table displaying the nanoparticles’ characterizations: 
• Variance in expected sizes or zeta potentials display the need to perform 
dilutions of the samples and/or filter the samples to ensure no 
conglomerates are present in the samples which could skew results. 
 
UV-Vis data displaying  the wavelength  and absorbance 
for  5 nm Citrate GNPs: 
• Shows a peak approximately around 500 nm 
• This peak  demonstrates what wavelength the particles 
absorb at  and, therefore, would have to be irradiated at in 
order to get nanoparticle heating. 
Image of various types of GNPs:  
(Left to Right) CMC, 5nm PEI, PEG, Citrate 20 nm 
• To determine nanoparticle effects on drug delivery when 
exteriorly bound to lipid vesicles as well as determining the 
effect of the particles on fluorescent dye—quenching or 
enhancement 
• The variations in surface chemistry can either produce a 
quenching or enhancement effect on the fluorescence 
emitted.  Once these effects are analyzed and a control 
curve is obtained, the measurement of the leakage rate of 
dye will be determined. 
• The development of the nanoparticle-lipid vesicle assembly 
will provide a new mechanism for drug delivery for patients 
that can provide site specific targeting upon thermal 
stimulation.   
• This targeting system can be utilized to release the desired 
medication to specific sites within the body; thus, replacing 
the current technique of full body chemical treatment such as 
chemotherapy. 
